None
EN
Stock Gets Fair Value Bump After Casdatifan Optimism
[]
BizToc
Never miss an important update on your stock portfolio and cut through the noise.
Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
The fair value estimate for Arcus Biosciences has shifted from US$35.75 to US$38.00, signaling a modest reset in…This story appeared on finance.yahoo.com , 2026-08-08 05:10:58.